1. 2019
  2. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

    Seremet, T., Jansen, Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P. & Neyns, B., 5 Sep 2019, In : Journal of Translational Medicine. 17, 1, 303.

    Research output: Contribution to journalArticle

  3. Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications

    Martens, S., Lefesvre, P., Nicolle, R., Biankin, A. V., Puleo, F., Van Laethem, J-L. & Rooman, I., Sep 2019, In : Annals of Oncology. 30, 9, p. 1428-1436 9 p.

    Research output: Contribution to journalArticle

  4. How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?

    Castelo-Branco, L., Aspeslagh, S., Kotecki, N. & Awada, A., Sep 2019, In : Current Opinion in Oncology. 31, 5, p. 420-423 4 p.

    Research output: Contribution to journalArticle

  5. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

    de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T., Bravenboer, B., Van der Auwera, B. J., Gorus, F., Roep, B. O., Aspeslagh, S., Neyns, B., Velkeniers, B. & Kharagjitsingh, A. V., Sep 2019, In : European Journal of Endocrinology. 181, 3, p. 363-374 12 p.

    Research output: Contribution to journalArticle

  6. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

    Robert, C., Ribas, A., Schachter, J., Arance, A., Grob, J-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C. M., Lotem, M., Larkin, J. M. G., Lorigan, P., Neyns, B., Blank, C. U., Petrella, T. M., Hamid, O., Su, S-C., Krepler, C., Ibrahim, N. & Long, G. V., Sep 2019, In : Lancet Oncology. 20, 9, p. 1239-1251 13 p.

    Research output: Contribution to journalArticle

  7. Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

    Rolfo, C., de Vos-Geelen, J., Isambert, N., Molife, L. R., Schellens, J. H. M., De Grève, J., Dirix, L., Grundtvig-Sørensen, P., Jerusalem, G., Leunen, K., Mau-Sørensen, M., Plummer, R., Learoyd, M., Bannister, W., Fielding, A. & Ravaud, A., Sep 2019, In : Clinical Pharmacokinetics. 58, 9, p. 1165-1174 10 p.

    Research output: Contribution to journalArticle

  8. Effect of lipegfilgrastim administration as prophylaxis of chemotherapy-induced neutropenia on dose modification and incidence of neutropenic events: real-world evidence from a non-interventional study in Belgium and Luxembourg

    Fontaine, C., Claes, N., Graas, M-P., Samani, K. K., Vuylsteke, P. & Vulsteke, C., 9 Aug 2019, In : Acta Clinica Belgica. p. 1-6 6 p.

    Research output: Contribution to journalArticle

  9. Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckRamses Forsyth

    Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T., Viana, L. D. S., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J. G., Psyrri, A., Vasilevskaya, I., Nangia, C. S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J. M., Asarawala, N. & 214 others, Nicolau, U. R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E. E. W., Eduardo Giglio, R., Raul Blajman, C., Mario Freue, J., Graciela Pilnik, N., Salvador Palazzo, F., McGrath, M., Fureder, T., Kornek, G., Pichler, A., Bauernhofer, T., Tinchon, C., Greil, R., Burian, M., Kienzer, H., Specenier, P., Sautois, B., Debruyne, P., Graas, M-P., Maes, A., Lonchay, C., Daisne, J-F., Fontaine, C., Castro Junior, G., de Oliveira, F., Pereira, R. P., Martins De Marchi, P. R., Viana, L. D. S., Martins Segalla, J. G., Nicolau, U. R., Lazaretti, N. S., Kulkarni, S., Alam, Y., Ho, C., Shenouda, G., Soulieres, D., Sultanem, K., Singh, S., Gonzalez Mella, P., Solis Campos, J. A., Holeckova, P., Prausova, J., Obermannova, R., Friborg, J., Specht, L., Elsaid, A. A., Minn, H., Martin, L., Rolland, F., Ceruse, P., Calais, G., Even, C., Guigay, J., Ferte, C., Peyrade, F., Duffaud, F., Champeaux-Orange, E., Coutte, A., Clatot, F., Fournel, P., Le Moal, L. B., Dietz, A., Gruenwald, V., Gauler, T., Guntinas-Lichius, O., Hildebrandt, G., Kuhnt, T., Schmidt, H-J., Henke, M., Rueckert, A., Brugger, W., Rotter, N., Mahlberg, R., Karavasilis, V., Fountzilas, G., Psyrri, D., Lang, I., Boer, A., Kocsis, J., Pajkos, G., Tamas, L., Anand, A. L., Sharma, A., Sharma, Voona, M., Pandy, A. S., Kumar, K., Nathan, R. K. P., Srinivasan, V., Zade, B., Jain, M., Srinivasa, B. J., Naik, R., Mohanty, B. K., Asarawala, N., Charas, T., Billan, S., Popovtzer, A., Licitra, L., Ferrari, D., Fao, P., Merlano, M., Rocca, M. C., Homma, A., Fujii, H., Tahara, M., Minami, S., Fujii, M., Yokota, T., Kadowaki, S., Muro, K., Kiyota, N., Okami, K., Yagi, T., Yoshino, K., Matsumoto, K., Takahashi, S., Matsuura, K., Alvarez Avitia, M. A., Gonzalez Riestra, H. J., van Meerten, E., Buter, J., Gelderblom, A. J., Kawecki, A., Golusinski, W., Dinis, J., Dinis, R., Ribeiro, L., Silva, R., Mansinho, H., Selezneva, I., Biakhov, M., Galiulin, R., Izmailov, A., Romanov, I., Vladimirov, V., Vinogradov, V., Mufazalov, F., Vasilevskaya, I., Baste, N., Ma del Campo, J., Mesia Nin, R., Lopez Pousa, A., Jose Grau de Castro, J., Reig, O., Vera, R., Trigo, J., Iglesias, L., Martinez Trufero, J., Vazquez, S., Rubio, B., Enrique Ales, J., Villar, E., Rubio, J., Escobar, Y., Soria, A., Chaves, M., Johansson, G. W., Friesland, S., Tell, R., Nyman, J., Rothschild, S., Zippelius, A., Rauch, D., Usluoglu, N., Gogunska, I., Zabolotniy, D., Vinnyk, Y., Burian, O., Harrington, K., Sykes, A., Peel, D., Lester, J., Robinson, M., Srinivasan, D., Fragkandrea-Nixon, I., Junor, E., Gollins, S., Evans, M., Newbold, K., Hwang, D., Schipani, S., Rizwanullah, M., Atiq, O., Arnaoutakis, K., Bauman, J., Burtness, B., Mehra, R., Kang, H., Chung, C., Davis, T., Haddad, R., Jimeno, A., Keresztes, R., Nangia, C., Ignatius, S-H., Su, Y. B., Overton, L. C., Garrison, M. A., Jeong, W., Wehbe, A., Argiris, A., Chiang, A., Morgensztern, D., Haigentz, M. J., Martincic, D. & Porosnicu, M., Aug 2019, In : JAMA Oncology. 5, 8, p. 1170-1180 11 p.

    Research output: Contribution to journalArticle

  10. Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

    Fontaine, C., Renard, V., Van den Bulk, H., Vuylsteke, P., Glorieux, P., Dopchie, C., Decoster, L., Vanacker, L., de Azambuja, E., De Greve, J., Awada, A. & Wildiers, H., Aug 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 607-615 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...57 Next

ID: 25692